HEADER CELL CYCLE 26-OCT-20 7KJS TITLE CRYSTAL STRUCTURE OF CDK2/CYCLIN E IN COMPLEX WITH PF-06873600 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2,P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: G1/S-SPECIFIC CYCLIN-E1; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCNE1, CCNE; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE INHIBITOR, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.MCTIGUE,Y.HE,R.A.FERRE REVDAT 3 18-OCT-23 7KJS 1 REMARK REVDAT 2 28-JUL-21 7KJS 1 JRNL REVDAT 1 23-JUN-21 7KJS 0 JRNL AUTH K.D.FREEMAN-COOK,R.L.HOFFMAN,D.C.BEHENNA,B.BORAS,J.CARELLI, JRNL AUTH 2 W.DIEHL,R.A.FERRE,Y.A.HE,A.HUI,B.HUANG,N.HUSER,R.JONES, JRNL AUTH 3 S.E.KEPHART,J.LAPEK,M.MCTIGUE,N.MILLER,B.W.MURRAY,A.NAGATA, JRNL AUTH 4 L.NGUYEN,S.NIESSEN,S.NINKOVIC,I.O'DOHERTY,M.A.ORNELAS, JRNL AUTH 5 J.SOLOWIEJ,S.C.SUTTON,K.TRAN,E.TSENG,R.VISSWANATHAN,M.XU, JRNL AUTH 6 L.ZEHNDER,Q.ZHANG,C.ZHANG,S.DANN JRNL TITL DISCOVERY OF PF-06873600, A CDK2/4/6 INHIBITOR FOR THE JRNL TITL 2 TREATMENT OF CANCER. JRNL REF J.MED.CHEM. V. 64 9056 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34110834 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00159 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 83.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 39893 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1955 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2206 REMARK 3 BIN FREE R VALUE : 0.2806 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 38 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4526 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.07860 REMARK 3 B22 (A**2) : -5.07860 REMARK 3 B33 (A**2) : 10.15720 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.238 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.208 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.236 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.209 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4675 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6351 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1605 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 767 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4675 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 595 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3884 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.95 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.91 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KJS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000251174. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39969 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.187 REMARK 200 RESOLUTION RANGE LOW (A) : 100.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.90 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : 0.07300 REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.2 REMARK 200 DATA REDUNDANCY IN SHELL : 12.70 REMARK 200 R MERGE FOR SHELL (I) : 1.16200 REMARK 200 R SYM FOR SHELL (I) : 1.11900 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER 2.11.7 REMARK 200 STARTING MODEL: 1W98 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6, .18 M MAGNESIUM REMARK 280 FORMATE, AND 9.0 % (W/V) PEG 20000, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 294.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.99100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 50.15200 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 50.15200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.49550 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 50.15200 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 50.15200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 112.48650 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 50.15200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.15200 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.49550 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 50.15200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.15200 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 112.48650 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 74.99100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 298 REMARK 465 GLU B 73 REMARK 465 ASN B 74 REMARK 465 LEU B 75 REMARK 465 TYR B 76 REMARK 465 PHE B 77 REMARK 465 GLN B 78 REMARK 465 GLY B 79 REMARK 465 SER B 80 REMARK 465 ILE B 81 REMARK 465 ILE B 82 REMARK 465 ALA B 83 REMARK 465 PRO B 84 REMARK 465 SER B 85 REMARK 465 ARG B 86 REMARK 465 GLY B 87 REMARK 465 VAL B 92 REMARK 465 LEU B 93 REMARK 465 SER B 94 REMARK 465 TRP B 95 REMARK 465 ASN B 245 REMARK 465 ASP B 246 REMARK 465 LEU B 247 REMARK 465 HIS B 248 REMARK 465 ALA B 358 REMARK 465 ARG B 359 REMARK 465 ALA B 360 REMARK 465 LYS B 361 REMARK 465 LYS B 362 REMARK 465 ALA B 363 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 73 CG CD OE1 OE2 REMARK 470 ASN A 74 CG OD1 ND2 REMARK 470 HIS A 295 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 99 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 -8.73 -140.74 REMARK 500 GLU A 73 -95.48 52.70 REMARK 500 ASP A 127 39.25 -146.91 REMARK 500 ASP A 145 81.38 57.05 REMARK 500 GLU A 162 90.22 -62.99 REMARK 500 VAL A 163 -40.06 -130.51 REMARK 500 SER A 181 -134.30 -155.36 REMARK 500 SER B 227 61.63 -118.64 REMARK 500 TYR B 243 64.21 -108.39 REMARK 500 SER B 293 -106.24 -148.42 REMARK 500 ASP B 350 33.14 -66.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 462 DISTANCE = 5.90 ANGSTROMS DBREF 7KJS A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 7KJS B 81 363 UNP P24864 CCNE1_HUMAN 96 378 SEQADV 7KJS GLU B 73 UNP P24864 EXPRESSION TAG SEQADV 7KJS ASN B 74 UNP P24864 EXPRESSION TAG SEQADV 7KJS LEU B 75 UNP P24864 EXPRESSION TAG SEQADV 7KJS TYR B 76 UNP P24864 EXPRESSION TAG SEQADV 7KJS PHE B 77 UNP P24864 EXPRESSION TAG SEQADV 7KJS GLN B 78 UNP P24864 EXPRESSION TAG SEQADV 7KJS GLY B 79 UNP P24864 EXPRESSION TAG SEQADV 7KJS SER B 80 UNP P24864 EXPRESSION TAG SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 291 GLU ASN LEU TYR PHE GLN GLY SER ILE ILE ALA PRO SER SEQRES 2 B 291 ARG GLY SER PRO LEU PRO VAL LEU SER TRP ALA ASN ARG SEQRES 3 B 291 GLU GLU VAL TRP LYS ILE MET LEU ASN LYS GLU LYS THR SEQRES 4 B 291 TYR LEU ARG ASP GLN HIS PHE LEU GLU GLN HIS PRO LEU SEQRES 5 B 291 LEU GLN PRO LYS MET ARG ALA ILE LEU LEU ASP TRP LEU SEQRES 6 B 291 MET GLU VAL CYS GLU VAL TYR LYS LEU HIS ARG GLU THR SEQRES 7 B 291 PHE TYR LEU ALA GLN ASP PHE PHE ASP ARG TYR MET ALA SEQRES 8 B 291 THR GLN GLU ASN VAL VAL LYS THR LEU LEU GLN LEU ILE SEQRES 9 B 291 GLY ILE SER SER LEU PHE ILE ALA ALA LYS LEU GLU GLU SEQRES 10 B 291 ILE TYR PRO PRO LYS LEU HIS GLN PHE ALA TYR VAL THR SEQRES 11 B 291 ASP GLY ALA CYS SER GLY ASP GLU ILE LEU THR MET GLU SEQRES 12 B 291 LEU MET ILE MET LYS ALA LEU LYS TRP ARG LEU SER PRO SEQRES 13 B 291 LEU THR ILE VAL SER TRP LEU ASN VAL TYR MET GLN VAL SEQRES 14 B 291 ALA TYR LEU ASN ASP LEU HIS GLU VAL LEU LEU PRO GLN SEQRES 15 B 291 TYR PRO GLN GLN ILE PHE ILE GLN ILE ALA GLU LEU LEU SEQRES 16 B 291 ASP LEU CYS VAL LEU ASP VAL ASP CYS LEU GLU PHE PRO SEQRES 17 B 291 TYR GLY ILE LEU ALA ALA SER ALA LEU TYR HIS PHE SER SEQRES 18 B 291 SER SER GLU LEU MET GLN LYS VAL SER GLY TYR GLN TRP SEQRES 19 B 291 CYS ASP ILE GLU ASN CYS VAL LYS TRP MET VAL PRO PHE SEQRES 20 B 291 ALA MET VAL ILE ARG GLU THR GLY SER SER LYS LEU LYS SEQRES 21 B 291 HIS PHE ARG GLY VAL ALA ASP GLU ASP ALA HIS ASN ILE SEQRES 22 B 291 GLN THR HIS ARG ASP SER LEU ASP LEU LEU ASP LYS ALA SEQRES 23 B 291 ARG ALA LYS LYS ALA MODRES 7KJS TPO A 160 THR MODIFIED RESIDUE HET TPO A 160 11 HET WG1 A 301 32 HETNAM TPO PHOSPHOTHREONINE HETNAM WG1 6-(DIFLUOROMETHYL)-8-[(1R,2R)-2-HYDROXY-2- HETNAM 2 WG1 METHYLCYCLOPENTYL]-2-{[1-(METHYLSULFONYL)PIPERIDIN-4- HETNAM 3 WG1 YL]AMINO}PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 WG1 C20 H27 F2 N5 O4 S FORMUL 4 HOH *144(H2 O) HELIX 1 AA1 PRO A 45 GLU A 57 1 13 HELIX 2 AA2 LEU A 87 SER A 94 1 8 HELIX 3 AA3 PRO A 100 HIS A 121 1 22 HELIX 4 AA4 LYS A 129 GLN A 131 5 3 HELIX 5 AA5 THR A 165 ARG A 169 5 5 HELIX 6 AA6 ALA A 170 LEU A 175 1 6 HELIX 7 AA7 THR A 182 ARG A 199 1 18 HELIX 8 AA8 SER A 207 GLY A 220 1 14 HELIX 9 AA9 GLY A 229 MET A 233 5 5 HELIX 10 AB1 ASP A 247 VAL A 252 1 6 HELIX 11 AB2 ASP A 256 LEU A 267 1 12 HELIX 12 AB3 SER A 276 ALA A 282 1 7 HELIX 13 AB4 HIS A 283 GLN A 287 5 5 HELIX 14 AB5 ASN B 97 LYS B 110 1 14 HELIX 15 AB6 HIS B 117 GLN B 121 5 5 HELIX 16 AB7 GLN B 126 TYR B 144 1 19 HELIX 17 AB8 HIS B 147 ALA B 163 1 17 HELIX 18 AB9 LEU B 172 GLU B 189 1 18 HELIX 19 AC1 LYS B 194 VAL B 201 1 8 HELIX 20 AC2 SER B 207 LEU B 222 1 16 HELIX 21 AC3 THR B 230 TYR B 243 1 14 HELIX 22 AC4 PRO B 256 LEU B 272 1 17 HELIX 23 AC5 ASP B 273 PHE B 279 5 7 HELIX 24 AC6 PRO B 280 PHE B 292 1 13 HELIX 25 AC7 SER B 294 GLY B 303 1 10 HELIX 26 AC8 GLN B 305 GLY B 327 1 23 HELIX 27 AC9 ALA B 338 ILE B 345 5 8 HELIX 28 AD1 ASP B 350 LYS B 357 1 8 SHEET 1 AA1 5 PHE A 4 GLU A 12 0 SHEET 2 AA1 5 VAL A 17 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O LEU A 32 N TYR A 19 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O LEU A 78 N LYS A 33 SHEET 5 AA1 5 LEU A 66 THR A 72 -1 N ASP A 68 O VAL A 79 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AA3 2 VAL A 123 LEU A 124 0 SHEET 2 AA3 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.36 LINK C TPO A 160 N HIS A 161 1555 1555 1.36 CISPEP 1 VAL A 154 PRO A 155 0 3.38 CRYST1 100.304 100.304 149.982 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009970 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009970 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006667 0.00000